FOCPX
Price
$30.62
Change
-$0.07 (-0.23%)
Updated
Aug 31 closing price
Net Assets
43.12B
GFACX
Price
$72.69
Change
-$0.73 (-0.99%)
Updated
Sep 1 closing price
Net Assets
342.42B
Interact to see
Advertisement

FOCPX vs GFACX

FOCPX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
FOCPX vs. GFACX commentary
Sep 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCPX is a StrongBuy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 342B vs. FOCPX (43.1B). FOCPX (0.00) and GFACX (0.00) have matching dividends . FOCPX was incepted earlier than GFACX: FOCPX (42 years) vs GFACX (25 years). GFACX (1.35) is less costly to investors than FOCPX (0.73). FOCPX is a more actively managed with annual turnover of: 53.00 vs. GFACX (32.00). FOCPX has a lower initial minimum investment than GFACX: FOCPX (0) vs GFACX (250). FOCPX annual gain was more profitable for investors over the last year : 30.37 vs. GFACX (1.05). FOCPX return over 5 years is better than : 41.25 vs. GFACX (3.72).
FOCPXGFACXFOCPX / GFACX
Total Expense Ratio0.731.3554%
Annual Report Gross Expense Ratio0.731.3554%
Fund Existence42 years25 years-
Gain YTD26.4009.094290%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets43.1B342B13%
Annual Yield % from dividends0.000.00-
Returns for 1 year30.371.052,904%
Returns for 3 years79.7934.35232%
Returns for 5 years41.253.721,110%
Returns for 10 years257.8479.51324%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSAX29.16N/A
N/A
Alger Health Sciences A
FAHYX13.18N/A
N/A
Fidelity Advisor Capital & Income M
ATWCX28.92N/A
N/A
AB Tax-Managed Wealth Apprec Strat C
MNBWX20.32N/A
N/A
Manning & Napier Pro-Blend Extnd Term W
RIGGX51.07-0.09
-0.18%
American Funds Intl Gr and Inc R-6